New eye drop aims to erase corneal scars in early trial
NCT ID NCT06257355
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests an experimental eye drop (CSB-001) in 20 people with recent corneal scars (from injury within the last 30 days). Participants use the drops 3-4 times daily for up to 14 days. The main goals are to check safety and see if the drops reduce scar size and improve vision.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORNEAL SCAR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Francis Price Jr, MD
RECRUITINGIndianapolis, Indiana, 46260, United States
-
Legacy Devers Eye Institute
RECRUITINGPortland, Oregon, 97210, United States
-
Loma Linda University Eye Institute
RECRUITINGLoma Linda, California, 92354, United States
-
Midwest Cornea Associates, LLC
RECRUITINGCarmel, Indiana, 46290, United States
-
Minnesota Eye Consultants
RECRUITINGMinnetonka, Minnesota, 55305, United States
-
Stuart A. Terry, MD PA
RECRUITINGSan Antonio, Texas, 78212, United States
-
Virginia Eye Consultants
RECRUITINGNorfolk, Virginia, 23502, United States